AKR1B10 and hepatocellular carcinoma: [28] AKR1B10 overexpression is also considered a marker for HCC.[16,36] This is relevant, since retinoids can influence key processes like cell growth and differentiation, and consequently carcinogenesis and patients with NASH have increased risk for HCC.